These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10504376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression and prognostic significance of apolipoprotein D in breast cancer.
    Díez-Itza I, Vizoso F, Merino AM, Sánchez LM, Tolivia J, Fernández J, Ruibal A, López-Otín C.
    Am J Pathol; 1994 Feb; 144(2):310-20. PubMed ID: 8311115
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
    Serra C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Merino AM, Baltasar A, Pérez-Vázquez MT, Medrano J.
    Int J Surg Investig; 2000 Feb; 2(3):183-92. PubMed ID: 12678518
    [Abstract] [Full Text] [Related]

  • 4. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.
    Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [Abstract] [Full Text] [Related]

  • 6. Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas.
    Vázquez J, González L, Merino A, Vizoso F.
    Gynecol Oncol; 2000 Mar; 76(3):340-7. PubMed ID: 10684708
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2005 Mar; 25(3A):1615-22. PubMed ID: 16033070
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, Ordiz I, Merino AM.
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [Abstract] [Full Text] [Related]

  • 10. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Jun; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein D expression in benign and malignant prostate tissues.
    Rodríguez JC, Díaz M, González LO, Sánchez J, Sánchez MT, Merino AM, Vizoso F.
    Int J Surg Investig; 2000 Jun; 2(4):319-26. PubMed ID: 12678535
    [Abstract] [Full Text] [Related]

  • 12. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A, Talieri M, Ardavanis A, Courtis N, Dimitriadis E, Yotis J, Tsiapalis CM, Trangas T.
    Cancer Res; 2000 Oct 01; 60(19):5427-33. PubMed ID: 11034084
    [Abstract] [Full Text] [Related]

  • 15. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.
    Acta Oncol; 2009 Oct 01; 48(4):514-21. PubMed ID: 19107621
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
    Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M.
    Br J Cancer; 2001 Jun 01; 84(11):1488-96. PubMed ID: 11384099
    [Abstract] [Full Text] [Related]

  • 17. Prolactin receptor expression in gynaecomastia and male breast carcinoma.
    Ferreira M, Mesquita M, Quaresma M, André S.
    Histopathology; 2008 Jul 01; 53(1):56-61. PubMed ID: 18613925
    [Abstract] [Full Text] [Related]

  • 18. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K.
    Virchows Arch; 2002 Jun 01; 440(6):589-93. PubMed ID: 12070597
    [Abstract] [Full Text] [Related]

  • 19. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015
    [Abstract] [Full Text] [Related]

  • 20. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Breast Cancer Res Treat; 2005 May 01; 91(2):125-32. PubMed ID: 15868440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.